13F-HR filed by Foresite Capital Management VI LLC
Foresite Capital Management VI LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 12 holding rows worth $330,838,998.
- Accession
- 0001104659-26-015412
- Filer
- CIK 2013341
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 12 entries on the cover page, a total value of $330,838,998 stated on the cover page (in dollars after the unit check, H1), rows summing to $330,838,998 with VALUE read as dollars as filed, 13F file number 028-25267. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 2,221,474 | $92,235,600 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E208 | COM NEW | 1,562,500 | $52,921,875 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 4,247,670 | $41,457,259 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,364,019 | $34,114,115 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 3,135,120 | $24,203,126 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 1,000,000 | $16,510,000 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 67,356 | $15,430,586 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 530,000 | $14,426,600 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 146,332 | $11,386,093 | dollars as filed | |
| ATAIBECKLEY INC | N0731H103 | Equity | 2,750,000 | $11,247,500 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 1,381,233 | $10,635,494 | dollars as filed | |
| HINGE HEALTH INC A | 433313103 | COMMON STOCK | 135,000 | $6,270,750 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-26-015412 | this filing | 2026-02-17 | acceptance time not in the bulk data set |